News / Events Press Releases IR Calendar Audio and Video Email Alerts All News 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Search terms Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City May 21, 2008 Pressure BioSciences, Inc. Reports First Quarter 2008 Financial Results and Provides Business Update May 1, 2008 Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates Apr 30, 2008 Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health Mar 19, 2008 Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update Mar 12, 2008 Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales Mar 11, 2008 Pressure BioSciences, Inc. Announces Move to New Corporate Offices Mar 10, 2008 Pressure BioSciences, Inc. to Discuss 2007 Financial Results and Provide Business Update Mar 6, 2008 Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating in Update Coverage by Dutton Associates Dec 18, 2007 Independent Research Group Reports that Pressure BioSciences' Award Winning ProteoSolve-LRS Technology Played a Significant Role in the Identification of Potential Biomarkers in Breast and Colon Cancer Tissue Dec 13, 2007 1... 38 39 40 41 42 43 44 45 46 47
Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City May 21, 2008
Pressure BioSciences, Inc. Reports First Quarter 2008 Financial Results and Provides Business Update May 1, 2008
Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates Apr 30, 2008
Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health Mar 19, 2008
Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating in Update Coverage by Dutton Associates Dec 18, 2007
Independent Research Group Reports that Pressure BioSciences' Award Winning ProteoSolve-LRS Technology Played a Significant Role in the Identification of Potential Biomarkers in Breast and Colon Cancer Tissue Dec 13, 2007
